Topics: Addiction | Practice Tools and Tips | Substance Abuse

Dr. Rosengren presents ten tips for motivational interviewing to help clinicians listen and help their clients struggling with addiction issues.

Topics: Addiction | Cognitive Behavioral Therapy | Substance Abuse

At its most basic, motivational interviewing is a conversation in which you are trying to help someone deal with ambivalence that prevents them from acting on a problematic behavior. At a more complex level, it has to do with things like paying attention to how the patient talks and what kind of language they’re using. In this interview, Dr. Rosengren discusses the language and process of motivational interviewing.

Topics: Depressive Disorder | Research Updates

Psilocybin, a naturally occurring and psychedelic compound of the Psilocybe species of mushrooms, has garnered the most attention. Psilocybin is essentially a serotonin 2A agonist. Theoretically, this action should mediate depressive symptoms, but we don’t know for sure because no available antidepressants are direct agonists of this receptor. Researchers from the United Kingdom set out to see if this is indeed the case.

Topics: Research Updates | Smoking Cessation Agents

Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.